HYPERPIGMENTATION
MELASMA
Melasma is a chronic, acquired disorder that operates across multiple biological layers simultaneously — epidermal, dermal,
and vascular. It is driven by a self-sustaining network of triggers that continues to stimulate melanocytes even in the absence of new UV exposure.
This is what makes it one of the most challenging pigmentation conditions to manage, and why single-target approaches so often fall short.
THE COMPLEXITY OF MELASMA
What sets melasma apart is the breadth of its biological drivers. It is not limited to
excess melanin production and involves a complex, self-reinforcing microenvironment that spans three distinct skin compartments.
At the epidermal level, stressed keratinocytes continuously release signals that activate melanocytes — even without new UV exposure. A compromised barrier amplifies this by increasing sensitivity to light, heat, and pollutants.
At the dermal level, aging fibroblasts lose their ability to regulate melanocyte activity, while chronic immune cell infiltration keeps low-grade inflammation running. In advanced cases, pigment cells migrate deeper into the skin, where they become harder to reach.
At the vascular level, increased vessel density raises local skin temperature and delivers pro-pigment signals directly to melanocytes, meaning vascular dysregulation actively sustains melasma regardless of other treatments.
A multi-level approach is essential to an effective melasma treatment.
THE ALPHASCIENCE SOLUTION
MELA BRIGHT [C+] was developed specifically to address melasma’s multi-pathway nature. Formulated with Cysteamine, a powerful yet safe depigmenting molecules which acts both on both tyrosinase-dependent and independent melanogenesis pathways, while simultaneously modulating redox and inflammatory signaling, it addresses melasma at a depth that few molecules can match.
MELA BRIGHT [C+] also leverages the pigment regulating action and free radical scavenging of L-Ascorbic Acid, and the strong vascular protecting and anti-inflammatory properties of Ginkgo Biloba.
This powerful and complementary antioxidant combination intercepts the melanogenesis and inflammatory cascades at multiple points, covering a scope of biological pathways that no single active could address alone.
Discover MELA BRIGHT [C+]
Strategies in melasma management
Managing melasma effectively requires thinking in three simultaneous directions: limiting the triggers that sustain it, reducing active pigment production, and where appropriate, removing existing pigment through in-office procedures.
Limiting triggers is non-negotiable and foundational. Broad-spectrum UV protection must be daily and consistent - not only during treatment, but as a permanent habit. Heat, hormonal factors, and irritating skincare routines are equally important to address.
Reducing pigment production can combine cosmeceuticals with systemic options such as tranexamic acid. Prescription approaches including short cycles of hydroquinone remain relevant in specific clinical contexts.
Procedural interventions such as superficial chemical peels, low-fluence Q-switched or picosecond lasers or microneedling can also offer significant and rapid improvements. However, a well-structured cosmeceutical protocol before and after any procedure is essential to protect the outcome and limit the risk of post-inflammatory hyperpigmentation.
Melasma is a chronic condition. It cannot really be cured but can be effectively managed and significantly improvedcwith consistency, realistic expectations, and an ongoing partnership with your practitioner.
